Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Thomas Curry Jr., M.D.

Co-Author

This page shows the publications co-authored by William Curry and Bryan Choi.
Connection Strength

5.065
  1. Commentary: The Glioma-Network Interface: A Review of the Relationship Between Glioma Molecular Subtype and Intratumoral Function. Neurosurgery. 2021 02 16; 88(3):E273-E274.
    View in: PubMed
    Score: 0.921
  2. A Common Rule for Resection of Glioblastoma in the Molecular Era. JAMA Oncol. 2020 04 01; 6(4):503-504.
    View in: PubMed
    Score: 0.867
  3. Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping. J Neurosurg. 2019 Mar 29; 132(4):1017-1023.
    View in: PubMed
    Score: 0.808
  4. IDH mutational status and the immune system in gliomas: a tale of two tumors? Transl Cancer Res. 2017 Oct; 6(Suppl 7):S1253-S1256.
    View in: PubMed
    Score: 0.727
  5. Implications of IDH mutations on immunotherapeutic strategies for malignant glioma. Neurosurg Focus. 2022 02; 52(2):E6.
    View in: PubMed
    Score: 0.246
  6. Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment. Neurosurgery. 2021 06 15; 89(1):E68-E69.
    View in: PubMed
    Score: 0.236
  7. Neurophysiologic Mapping of Thalamocortical Tract in Asleep Craniotomies: Promising Results From an Early Experience. Oper Neurosurg (Hagerstown). 2021 01 13; 20(2):219-225.
    View in: PubMed
    Score: 0.229
  8. IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice. Oncoimmunology. 2020 08 20; 9(1):1806662.
    View in: PubMed
    Score: 0.223
  9. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer. 2019 11 14; 7(1):304.
    View in: PubMed
    Score: 0.211
  10. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat Biotechnol. 2019 09; 37(9):1049-1058.
    View in: PubMed
    Score: 0.206
  11. (R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas. Transl Cancer Res. 2019 Mar; 8(Suppl 2):S167-S170.
    View in: PubMed
    Score: 0.201
  12. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons. Neurosurg Focus. 2018 06; 44(6):E13.
    View in: PubMed
    Score: 0.191
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.